{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T02:40:50Z","timestamp":1777948850249,"version":"3.51.4"},"reference-count":21,"publisher":"Walter de Gruyter GmbH","issue":"1","license":[{"start":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T00:00:00Z","timestamp":1765756800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,19]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"j_pp-2025-0037_abs_001\">\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To evaluate current postoperative management strategies for incidentally discovered, completely resected low-grade appendiceal mucinous neoplasms (LAMNs) within the French RENAPE network and to assess the need for a new national consensus.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_pp-2025-0037_abs_002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A national survey was conducted among RENAPE expert centers using a structured questionnaire based on standardized postoperative risk scenarios. Survey items addressed surveillance strategies, indications for reoperation, and use of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_pp-2025-0037_abs_003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Ninety-one percent of centers responded. All reported systematic multidisciplinary discussion, centralized pathology and imaging review, standardized imaging, and tumor marker assessment. Marked heterogeneity was observed. For low-risk patients (R0 resection, no perforation, no extra-appendiceal mucin), 50\u202f% recommended no follow-up and 50\u202f% proposed long-term MRI surveillance. In intermediate-risk cases (limited perforation or adjacent mucin), 80\u202f% favored MRI follow-up, while 20\u202f% recommended diagnostic laparoscopy or prophylactic CRS-HIPEC. In high-risk scenarios with radiologic suspicion of implants, 60% proposed early CRS-HIPEC, whereas others preferred laparoscopic assessment or surveillance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_pp-2025-0037_abs_004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This survey highlights wide variation in postoperative strategies for LAMNs within RENAPE, especially in intermediate-risk cases. While consensus exists on centralized review and imaging, significant evidence gaps persist regarding prophylactic HIPEC. These findings underscore the need for harmonized, evidence-based protocols and prospective data collection.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1515\/pp-2025-0037","type":"journal-article","created":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T05:57:16Z","timestamp":1765605436000},"page":"49-54","source":"Crossref","is-referenced-by-count":0,"title":["Proposed strategy after complete LAMN (low-grade appendiceal mucinous neoplasm) resection by different RENAPE units: need for a new consensus?"],"prefix":"10.1515","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6076-004X","authenticated-orcid":false,"given":"Christian","family":"Mouawad","sequence":"first","affiliation":[{"name":"SSPC (Simplification des Soins des Patients Complexes) Clinical Research Unit, UPJV 7518, Universit\u00e9 de Picardie Jules-Verne , Amiens , France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdelkader","family":"Taibi","sequence":"additional","affiliation":[{"name":"Digestive Surgery Department , Dupuytren Limoges University Hospital , Limoges , France"},{"name":"CNRS, XLIM, UMR 7252, University Limoges , Limoges , France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6965-3697","authenticated-orcid":false,"given":"Olivia","family":"Sgarbura","sequence":"additional","affiliation":[{"name":"Institut du Cancer de Montpellier, Service de Chirurgie Digestive Oncologique , Montpellier , France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dahbia","family":"Djelil","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris Cit\u00e9, CNRS UMR 8175, Inserm UMR-S 1334, NABI , Paris , France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Marchal","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology , Gustave Roussy Cancer Campus , Villejuif , France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle","family":"Sourrouille","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology , Gustave Roussy Cancer Campus , Villejuif , France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diane","family":"Goere","sequence":"additional","affiliation":[{"name":"Department of Digestive, Carcinological and Endocrine Surgery , H\u00f4pital Saint-Louis, AP-HP , Paris , France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Glehen","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Claude Bernard Lyon 1, UR3738-Centre pour l\u2019Innovation en Canc\u00e9rologie de Lyon (CICLY) , Lyon , France"},{"name":"Hospices Civils de Lyon, H\u00f4pital Lyon Sud, Service de Chirurgie Digestive , Lyon , France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gwenael","family":"Ferron","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology , IUCT Oncopole,\u00a0Institut Universitaire du Cancer de Toulouse , Toulouse , France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fr\u00e9deric","family":"Dumont","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology , Institut de Canc\u00e9rologie de Lorraine, Vandoeuvre-les-Nancy, France ; CRAN, UMR 7039 Universit\u00e9 de Lorraine, CNRS , Vandoeuvre-les-Nancy , France"},{"name":"Department of Surgical Oncology , Institut de Canc\u00e9rologie de l\u2019Ouest , Saint Herblain , France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Courvoisier Clement","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology , CHU Poitiers , Poitiers , France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9cile","family":"Brigand","sequence":"additional","affiliation":[{"name":"Department of General and Digestive Surgery , H\u00f4pital de Hautepierre - H\u00f4pitaux Universitaires , Strasbourg , France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koceila Lamine","family":"Amroun","sequence":"additional","affiliation":[{"name":"Department of General, Digestive and\u00a0Endocrine Surgery , Christian Cabrol Hospital University , Reims , France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karine","family":"Abboud","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology , Hopital Nord St Etienne , St \u00c9tienne , France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8713-7821","authenticated-orcid":false,"given":"Laurent","family":"Villeneuve","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Claude Bernard Lyon 1, UR3738-Centre pour l\u2019Innovation en Canc\u00e9rologie de Lyon (CICLY) , Lyon , France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Pocard","sequence":"additional","affiliation":[{"name":"Department of Digestive, Hepatobiliary and Liver Transplantation Surgery , AP-HP, H\u00f4pital de la Piti\u00e9-Salp\u00eatri\u00e8re , Paris , France"},{"name":"Universit\u00e9 Paris Cit\u00e9, CNRS UMR 8175, Inserm UMR-S 1334, NABI , Paris , France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2025,12,15]]},"reference":[{"key":"2026050315471970196_j_pp-2025-0037_ref_001","doi-asserted-by":"crossref","unstructured":"Pai, RK, Longacre, TA. Appendiceal mucinous tumors and pseudomyxoma peritonei: histologic features, diagnostic problems, and proposed classification. Adv Anat Pathol 2005;12:291\u2013311. https:\/\/doi.org\/10.1097\/01.pap.0000194625.05137.51.","DOI":"10.1097\/01.pap.0000194625.05137.51"},{"key":"2026050315471970196_j_pp-2025-0037_ref_002","doi-asserted-by":"crossref","unstructured":"Carr, NJ, Cecil, TD, Mohamed, F, Sobin, LH, Sugarbaker, PH, Gonz\u00e1lez-Moreno, S, et al.. A consensus for classification and pathologic reporting of pseudomyxoma peritonei and associated appendiceal neoplasia: the results of the Peritoneal Surface Oncology Group International (PSOGI) modified Delphi process. Am J Surg Pathol 2016;40:14\u201326. https:\/\/doi.org\/10.1097\/PAS.0000000000000535.","DOI":"10.1097\/PAS.0000000000000535"},{"key":"2026050315471970196_j_pp-2025-0037_ref_003","doi-asserted-by":"crossref","unstructured":"Esquivel, J, Sugarbaker, PH. Clinical presentation of the pseudomyxoma peritonei syndrome. Br J Surg 2000;87:1414\u201318. https:\/\/doi.org\/10.1046\/j.1365-2168.2000.01553.x.","DOI":"10.1046\/j.1365-2168.2000.01553.x"},{"key":"2026050315471970196_j_pp-2025-0037_ref_004","doi-asserted-by":"crossref","unstructured":"Villeneuve, L, Passot, G, Glehen, O, Isaac, S, Bibeau, F, Rousset, P, et al.. The RENAPE observational registry: rationale and framework of the rare peritoneal tumors French patient registry. Orphanet J Rare Dis 2017;12:37. https:\/\/doi.org\/10.1186\/s13023-017-0571-y.","DOI":"10.1186\/s13023-017-0571-y"},{"key":"2026050315471970196_j_pp-2025-0037_ref_005","doi-asserted-by":"crossref","unstructured":"Delhorme, JB, Villeneuve, L, Bouch\u00e9, O, Averous, G, Dohan, A, Gornet, JM, et al.. Appendiceal tumors and pseudomyxoma peritonei: French Intergroup Clinical Practice Guidelines for diagnosis, treatments and follow-up (RENAPE, RENAPATH, SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, SFR). Dig Liver Dis 2022;54:30\u20139. https:\/\/doi.org\/10.1016\/j.dld.2021.10.005.","DOI":"10.1016\/j.dld.2021.10.005"},{"key":"2026050315471970196_j_pp-2025-0037_ref_006","doi-asserted-by":"crossref","unstructured":"Govaerts, K, Lurvink, RJ, De Hingh, IHJT, Van der Speeten, K, Villeneuve, L, Kusamura, S, et al.. Appendiceal tumours and pseudomyxoma peritonei: literature review with PSOGI\/EURACAN clinical practice guidelines for diagnosis and treatment. Eur J Surg Oncol 2021;47:11\u201335. https:\/\/doi.org\/10.1016\/j.ejso.2020.02.012.","DOI":"10.1016\/j.ejso.2020.02.012"},{"key":"2026050315471970196_j_pp-2025-0037_ref_007","doi-asserted-by":"crossref","unstructured":"Smeenk, RM, van Velthuysen, MLF, Verwaal, VJ, Zoetmulder, FA N. Appendiceal neoplasms and pseudomyxoma peritonei: a population based study. Eur J Surg Oncol 2008;34:196\u2013201. https:\/\/doi.org\/10.1016\/j.ejso.2007.04.002.","DOI":"10.1016\/j.ejso.2007.04.002"},{"key":"2026050315471970196_j_pp-2025-0037_ref_008","doi-asserted-by":"crossref","unstructured":"Chua, TC, Moran, BJ, Sugarbaker, PH, Levine, EA, Glehen, O, Gilly, FN, et al.. Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J\u00a0Clin Oncol 2012;30:2449\u201356. https:\/\/doi.org\/10.1200\/JCO.2011.39.7166.","DOI":"10.1200\/jco.2012.30.4_suppl.532"},{"key":"2026050315471970196_j_pp-2025-0037_ref_009","doi-asserted-by":"crossref","unstructured":"Chicago Consensus Working Group. The Chicago consensus on peritoneal surface malignancies: management of appendiceal neoplasms. Cancer 2020;126:2525\u201333. https:\/\/doi.org\/10.1002\/cncr.32881.","DOI":"10.1002\/cncr.32881"},{"key":"2026050315471970196_j_pp-2025-0037_ref_010","doi-asserted-by":"crossref","unstructured":"Mouawad, C, Bardier, A, Wagner, M, Doat, S, Djelil, D, Fawaz, J, et al.. Active surveillance for low-grade appendiceal mucinous neoplasm (LAMN). Pleura Peritoneum 2024;9:31\u20137. https:\/\/doi.org\/10.1515\/pp-2023-0032.","DOI":"10.1515\/pp-2023-0032"},{"key":"2026050315471970196_j_pp-2025-0037_ref_011","doi-asserted-by":"crossref","unstructured":"Lakmal, C, Chakrabarty, B, Tan, C, Larby, L, Kochhar, R, Fish, R, et al.. The risk of developing pseudomyxoma peritonei from a non-perforated low grade appendiceal mucinous neoplasm found at appendicectomy. Eur J Surg Oncol 2024;50:108600. https:\/\/doi.org\/10.1016\/j.ejso.2024.108600.","DOI":"10.1016\/j.ejso.2024.108600"},{"key":"2026050315471970196_j_pp-2025-0037_ref_012","doi-asserted-by":"crossref","unstructured":"Lohani, KR, Sonani, H, Buckarma, E, Lee, HE, Vierkant, RA, Thiels, CA, et al.. Risk stratification of surveillance for low-grade appendiceal mucinous neoplasms. J\u00a0Gastrointest Surg 2024;28:1906\u201311. https:\/\/doi.org\/10.1016\/j.gassur.2024.08.010.","DOI":"10.1016\/j.gassur.2024.08.010"},{"key":"2026050315471970196_j_pp-2025-0037_ref_013","doi-asserted-by":"crossref","unstructured":"Guaglio, M, Sinukumar, S, Kusamura, S, Milione, M, Pietrantonio, F, Battaglia, L, et al.. Clinical surveillance after macroscopically complete surgery for low-grade appendiceal mucinous neoplasms (LAMN) with or without limited peritoneal spread: long-term results in a prospective series. Ann Surg Oncol 2018;25:878\u201384. https:\/\/doi.org\/10.1245\/s10434-018-6341-9.","DOI":"10.1245\/s10434-017-6305-5"},{"key":"2026050315471970196_j_pp-2025-0037_ref_014","doi-asserted-by":"crossref","unstructured":"Arnason, T, Kamionek, M, Yang, M, Yantiss, RK, Misdraji, J. Significance of proximal margin involvement in low-grade appendiceal mucinous neoplasms. Arch Pathol Lab Med 2015;139:518\u201321. https:\/\/doi.org\/10.5858\/arpa.2014-0246-OA.","DOI":"10.5858\/arpa.2014-0246-OA"},{"key":"2026050315471970196_j_pp-2025-0037_ref_015","doi-asserted-by":"crossref","unstructured":"Dartigues, P, Kepenekian, V, Illac-Vauquelin, C, Verriele, V, Fontaine, J, Isaac, S, et al.. Insights into the clinical prognosis of high-grade appendiceal mucinous neoplasms. Am J Surg Pathol 2025;49:499\u2013507. https:\/\/doi.org\/10.1097\/PAS.0000000000002373.","DOI":"10.1097\/PAS.0000000000002373"},{"key":"2026050315471970196_j_pp-2025-0037_ref_016","doi-asserted-by":"crossref","unstructured":"K\u00f6hler, F, Arnold, D, Aust, D, Betge, J, Brecht, IB, Germer, CT, et al.. German S2k-guideline on diagnostics, treatment and surveillance of low-grade appendiceal mucinous neoplasms (LAMN). Eur J Cancer Oxf Engl 2025;222:115430. https:\/\/doi.org\/10.1016\/j.ejca.2025.115430.","DOI":"10.1016\/j.ejca.2025.115430"},{"key":"2026050315471970196_j_pp-2025-0037_ref_017","doi-asserted-by":"crossref","unstructured":"Hannan, E, Roman, LM, O\u2019Brien, L, Mueller, A, Staunton, O, Shields, C, et al.. Surveillance of low-grade appendiceal mucinous neoplasms for progression to pseudomyxoma peritonei: results from a structured surveillance programme. Colorectal Dis 2024;27:e17266. https:\/\/doi.org\/10.1111\/codi.17266.","DOI":"10.1111\/codi.17266"},{"key":"2026050315471970196_j_pp-2025-0037_ref_018","doi-asserted-by":"crossref","unstructured":"Wong, M, Barrows, B, Gangi, A, Kim, S, Mertens, RB, Dhall, D. Low-grade appendiceal mucinous neoplasms: a single institution experience of 64 cases with clinical Follow-up and correlation with the current (Eighth edition) AJCC staging. Int J Surg Pathol 2020;28:252\u20138. https:\/\/doi.org\/10.1177\/1066896919883679.","DOI":"10.1177\/1066896919883679"},{"key":"2026050315471970196_j_pp-2025-0037_ref_019","doi-asserted-by":"crossref","unstructured":"Roxburgh, CS, Fenig, YM, Cercek, A, Shia, J, Rassam, RM, Paty, PB, et al.. Outcomes of low-grade appendiceal mucinous neoplasms with remote acellular mucinous peritoneal deposits. Ann Surg Oncol 2019;26:118\u201324. https:\/\/doi.org\/10.1245\/s10434-018-7003-7.","DOI":"10.1245\/s10434-018-7003-7"},{"key":"2026050315471970196_j_pp-2025-0037_ref_020","doi-asserted-by":"crossref","unstructured":"Lin, YL, Xu, DZ, Li, XB, Yan, FC, Xu, HB, Peng, Z, et al.. Consensuses and controversies on pseudomyxoma peritonei: a review of the published consensus statements and guidelines. Orphanet J Rare Dis 2021;16:85. https:\/\/doi.org\/10.1186\/s13023-021-01723-6.","DOI":"10.1186\/s13023-021-01723-6"},{"key":"2026050315471970196_j_pp-2025-0037_ref_021","doi-asserted-by":"crossref","unstructured":"Portela, DS, Jain, A, Flood, M, Lavelle, A, Guerra, G, Patel, M, et al.. The microbiome of pseudomyxoma peritonei: a scoping review. Pleura Peritoneum 2025;10:35\u201350. https:\/\/doi.org\/10.1515\/pp-2024-0016.","DOI":"10.1515\/pp-2024-0016"}],"container-title":["Pleura and Peritoneum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/pp-2025-0037\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/pp-2025-0037\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T21:00:06Z","timestamp":1777842006000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/pp-2025-0037\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,15]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12,16]]},"published-print":{"date-parts":[[2026,3,19]]}},"alternative-id":["10.1515\/pp-2025-0037"],"URL":"https:\/\/doi.org\/10.1515\/pp-2025-0037","relation":{},"ISSN":["2364-7671","2364-768X"],"issn-type":[{"value":"2364-7671","type":"print"},{"value":"2364-768X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,15]]}}}